In all samples from patients with tumour, GPER1 gene mutations decreased OS, DFS, DSS and PFS, suggesting that GPER1 gene alterations play an important role in cancer progression and that the associated changes in GPER1 expression levels could provide prognostic value for patients with tumour. The gene discussed is GPER1; the disease is cancer.